US based medical technology company Medtronic has introduced CardioGuide implant system in the US and Canada.
The real-time navigation system is designed for determining the real-time location to place left-ventricular (LV) electrode lead for implanting cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D).
The CardioGuide implant system features a 3-D imaging software that projects a roadmap and the targeted lead placement onto an overlay of the patient's heart.
The device also features a physician monitor that displays the system inside the procedure room or cath lab and a tablet computer comprising a touch screen and stylus is used as a tableside console in the procedure room.
Medtronic, which has a licensing agreement with Paieon for the global commercialization of CardioGuide system, said the system is also compatible with all its CRT devices including the Viva/Brava portfolio.
Medtronic cardiac rhythm disease management business medical director and heart failure vice president and general manager David Steinhaus said, "This is yet another example of our commitment to offering physicians the most advanced medical technology available to help improve CRT response and ensure the best quality of care for all heart failure patients."
The company said a new software version for the system that also analyzes the motion of select cardiac vessels on the left side of the heart will be available later in 2013.
